
Co-Diagnostics Inc Investor Relations Material
Latest events

Q3 2024
Co-Diagnostics Inc
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Co-Diagnostics Inc
Access all reports
Co-Diagnostics, Inc. is a molecular diagnostics company that develops and manufactures diagnostic testing products. The company's core focus is on creating and commercializing molecular technologies that detect infectious diseases, as well as other genetic conditions. Co-Diagnostics utilizes its proprietary CoPrimer technology to design highly accurate and cost-effective diagnostic tests. The company serves the healthcare sector, offering its products to laboratories, hospitals, and healthcare providers globally, with applications in human diagnostics, agriculture, and animal testing. The company is headquartered in Salt Lake City, Utah, and its shares are listed on the NASDAQ.
Latest articles
)
Adobe: Equipping the Architects of Digital Expression
The story of how Adobe grew from a small garage upstart to one of the largest and most dominant software companies in the world.
21 Mar 2025
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
Ticker symbol
CODX
Country
🇺🇸 United States